Onset of Clinical Response With Deucravacitinib in Patients With Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b 4 PSORIATYK SCALP Trial. J of Skin 2025, 9 (2), s539. https://doi.org/10.25251/skin.10.supp.539.